These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8204416)
1. Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States. Rauws AG; Groen K Chirality; 1994; 6(2):72-5. PubMed ID: 8204416 [TBL] [Abstract][Full Text] [Related]
2. International harmonisation of regulatory requirements. Holmes M; Hill RE Rev Sci Tech; 2007 Aug; 26(2):415-20. PubMed ID: 17892161 [TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037 [TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934 [TBL] [Abstract][Full Text] [Related]
5. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements. Cocchetto DM Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349 [TBL] [Abstract][Full Text] [Related]
6. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice. Food and Drug Administration, HHS Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039 [TBL] [Abstract][Full Text] [Related]
7. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2003 Jan; 68(11):2339-40. PubMed ID: 12532979 [TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Nov; 66(216):56332-3. PubMed ID: 12358038 [TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880 [TBL] [Abstract][Full Text] [Related]
10. Animal toxicology studies on new medicines and their relationship to clinical exposure: a review of international recommendations. Scales MD; Mahoney K Adverse Drug React Toxicol Rev; 1991; 10(3):155-68. PubMed ID: 1747442 [TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036 [TBL] [Abstract][Full Text] [Related]
12. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice. Food and Drug Administration, HHS Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425 [TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358 [TBL] [Abstract][Full Text] [Related]
14. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216 [TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113 [TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; evaluation of stability data; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712 [TBL] [Abstract][Full Text] [Related]
18. International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice. Food and Drug Administration, HHS Fed Regist; 2000 Dec; 65(251):83041-63. PubMed ID: 12356095 [TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice. Food and Drug Administration, HHS Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944 [TBL] [Abstract][Full Text] [Related]
20. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS. Fed Regist; 1999 Aug; 64(159):44928-35. PubMed ID: 12356094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]